fea
赞了
$Aptevo Therapeutics (APVO.US)$
Aptevo正在进行的RAINIER试验中，首例患者在治疗的第30天内白血病细胞减少90％，延续了Mipletamig AML研究中观察到的总体疗效趋势
aptevo therapeutics（纳斯达克: APVO）报告称，早期RAINIER试验取得了令人振奋的成果，第一个接受mipletamig治疗的患者在30天内白血病细胞减少了90%。
该试验评估mipletamig作为Ac...的一线治疗。
Aptevo正在进行的RAINIER试验中，首例患者在治疗的第30天内白血病细胞减少90％，延续了Mipletamig AML研究中观察到的总体疗效趋势
aptevo therapeutics（纳斯达克: APVO）报告称，早期RAINIER试验取得了令人振奋的成果，第一个接受mipletamig治疗的患者在30天内白血病细胞减少了90%。
该试验评估mipletamig作为Ac...的一线治疗。
已翻译
fea
赞了
$BTC Digital (BTCT.US)$ $Bitcoin Depot (BTM.US)$ $TeraWulf (WULF.US)$ $MARA Holdings (MARA.US)$ $毫微 (NA.US)$ $Nukkleus (NUKK.US)$ $MicroAlgo (MLGO.US)$ $Bit Digital (BTBT.US)$ $CleanSpark (CLSK.US)$ $Hut 8 (HUT.US)$ $Hive Blockchain (HIVE.US)$ $MicroStrategy (MSTR.US)$ $Block (SQ.US)$ $嘉楠科技 (CAN.US)$ $Genius Group (GNS.US)$ $OneMedNet (ONMD.US)$ $Next Technology (NXTT.US)$ $Semler Scientific, Inc. (SMLR.US)$ $Riot Platforms (RIOT.US)$ $Cipher Mining (CIFR.US)$ $Core Scientific (CORZ.US)$ $Greenidge Generation (GREE.US)$ $Sphere 3d (ANY.US)$ $Bitfarms (BITF.US)$ $AgriFORCE Growing (AGRI.US)$ $Solidion Technology (STI.US)$ $BTCS Inc (BTCS.US)$ $Greenidge Generation (GREE.US)$
已翻译
26
26
fea
赞了
OCR集团Bhd（交易所：OCR），目前每股仅交易3美分，似乎被严重低估，尤其是在他们最近的带有免费认股权证的权益发行后。
如今拥有适度的市值以及在房地产开发和施工行业拥有强大基本面（每个财政年度轻松实现超过1亿林吉特的营业收入），这种低估为投资者提供了一个吸引人的入场点。
公司...
如今拥有适度的市值以及在房地产开发和施工行业拥有强大基本面（每个财政年度轻松实现超过1亿林吉特的营业收入），这种低估为投资者提供了一个吸引人的入场点。
公司...
已翻译
3
2
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)